Kestra Advisory Services LLC lowered its position in Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Rating) by 16.3% in the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 56,467 shares of the consumer goods maker’s stock after selling 11,001 shares during the quarter. Kestra Advisory Services LLC’s holdings in Anheuser-Busch InBev SA/NV were worth $3,390,000 as of its most recent SEC filing.
Several other large investors also recently added to or reduced their stakes in BUD. Fisher Asset Management LLC boosted its stake in Anheuser-Busch InBev SA/NV by 2.8% in the 3rd quarter. Fisher Asset Management LLC now owns 9,273,506 shares of the consumer goods maker’s stock worth $418,792,000 after purchasing an additional 248,858 shares during the period. Capital International Investors boosted its stake in Anheuser-Busch InBev SA/NV by 3.6% in the 1st quarter. Capital International Investors now owns 7,344,543 shares of the consumer goods maker’s stock worth $444,214,000 after purchasing an additional 252,914 shares during the period. Royal Bank of Canada boosted its stake in Anheuser-Busch InBev SA/NV by 6.7% in the 3rd quarter. Royal Bank of Canada now owns 6,680,188 shares of the consumer goods maker’s stock worth $301,678,000 after purchasing an additional 418,162 shares during the period. Dynamo Administracao de Recursos Ltda. boosted its stake in Anheuser-Busch InBev SA/NV by 37.8% in the 3rd quarter. Dynamo Administracao de Recursos Ltda. now owns 4,926,864 shares of the consumer goods maker’s stock worth $222,497,000 after purchasing an additional 1,351,899 shares during the period. Finally, UBS Group AG boosted its stake in Anheuser-Busch InBev SA/NV by 87.3% in the 3rd quarter. UBS Group AG now owns 1,945,327 shares of the consumer goods maker’s stock worth $87,851,000 after purchasing an additional 906,881 shares during the period. Hedge funds and other institutional investors own 5.53% of the company’s stock.
Anheuser-Busch InBev SA/NV Stock Performance
NYSE:BUD opened at $64.36 on Wednesday. The business has a 50 day moving average of $61.70 and a 200 day moving average of $57.69. The company has a market capitalization of $111.79 billion, a price-to-earnings ratio of 21.74, a PEG ratio of 1.88 and a beta of 1.24. Anheuser-Busch InBev SA/NV has a 1-year low of $44.51 and a 1-year high of $67.09. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.67 and a quick ratio of 0.48.
Anheuser-Busch InBev SA/NV Increases Dividend
The business also recently declared an annual dividend, which will be paid on Thursday, June 8th. Shareholders of record on Thursday, May 4th will be paid a $0.611 dividend. This is a boost from Anheuser-Busch InBev SA/NV’s previous annual dividend of $0.41. This represents a yield of 0.95%. The ex-dividend date is Wednesday, May 3rd. Anheuser-Busch InBev SA/NV’s payout ratio is 13.51%.
Wall Street Analysts Forecast Growth
BUD has been the subject of a number of research analyst reports. Deutsche Bank Aktiengesellschaft downgraded Anheuser-Busch InBev SA/NV from a “buy” rating to a “hold” rating in a research report on Thursday, January 12th. StockNews.com downgraded Anheuser-Busch InBev SA/NV from a “strong-buy” rating to a “buy” rating in a research report on Monday. Finally, UBS Group downgraded Anheuser-Busch InBev SA/NV from a “neutral” rating to a “sell” rating in a research report on Thursday, January 12th. Two analysts have rated the stock with a sell rating, three have given a hold rating and seven have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $64.70.
Anheuser-Busch InBev SA/NV Company Profile
Anheuser-Busch InBev SA/NV operates as a holding company, which engages in the manufacture and distribution of alcoholic and non-alcoholic beverages. It operates through the following geographical segments: North America, Middle Americas, South America, EMEA, Asia Pacific, and Global Export and Holding Companies.
Read More
- Get a free copy of the StockNews.com research report on Anheuser-Busch InBev SA/NV (BUD)
- Gamida Cell Stock Jumps Over 100% on FDA Approval
- Insiders Buy EasyJet, Regularly And Repeatedly
- Bank of America Beats Earnings, Renews Investor Upside Potential
- The Analysts See A Bright Future For Sunrun
- J.B. Hunt: Economic Contraction And A Buying Opportunity
Want to see what other hedge funds are holding BUD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Rating).
Receive News & Ratings for Anheuser-Busch InBev SA/NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anheuser-Busch InBev SA/NV and related companies with MarketBeat.com's FREE daily email newsletter.
